Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001641172-25-018242
Filing Date
2025-07-08
Accepted
2025-07-09 12:04:46
Documents
18
Period of Report
2025-07-08

Document Format Files

Seq Description Document Type Size
1 DEF 14A formdef14a.htm   iXBRL DEF 14A 686041
2 GRAPHIC formdef14a_001.jpg GRAPHIC 13743
3 GRAPHIC proxy_001.jpg GRAPHIC 342710
4 GRAPHIC proxy_002.jpg GRAPHIC 365745
  Complete submission text file 0001641172-25-018242.txt   2961477

Data Files

Seq Description Document Type Size
5 XBRL SCHEMA FILE cdt-20241231.xsd EX-101.SCH 3427
6 XBRL DEFINITION FILE cdt-20241231_def.xml EX-101.DEF 5352
7 XBRL LABEL FILE cdt-20241231_lab.xml EX-101.LAB 52563
8 XBRL PRESENTATION FILE cdt-20241231_pre.xml EX-101.PRE 39420
20 EXTRACTED XBRL INSTANCE DOCUMENT formdef14a_htm.xml XML 3095
Mailing Address 4851 TAMIAMI TRAIL NORTH SUITE 200 NAPLES FL 34103
Business Address 4851 TAMIAMI TRAIL NORTH SUITE 200 NAPLES FL 34103 (646) 491 9132
CONDUIT PHARMACEUTICALS INC. (Filer) CIK: 0001896212 (see all company filings)

EIN.: 873272543 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-41245 | Film No.: 251112754
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)